Dezerv

Fund Overview

Fund Size

Fund Size

₹943 Cr

Expense Ratio

Expense Ratio

1.35%

ISIN

ISIN

INF789F01TO9

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

01 Jan 2013

About this fund

UTI Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by UTI Mutual Fund. This fund has been in existence for 11 years, 4 months and 19 days, having been launched on 01-Jan-13.
As of 17-May-24, it has a Net Asset Value (NAV) of ₹250.97, Assets Under Management (AUM) of 943.34 Crores, and an expense ratio of 1.35%.
  • UTI Healthcare Fund Direct Growth has given a CAGR return of 15.72% since inception.
  • The fund's asset allocation comprises around 98.46% in equities, 0.13% in debts, and 1.41% in cash & cash equivalents.
  • You can start investing in UTI Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+52.01%

+51.54% (Cat Avg.)

3 Years

+13.92%

+13.98% (Cat Avg.)

5 Years

+24.34%

+24.42% (Cat Avg.)

10 Years

+15.30%

+16.65% (Cat Avg.)

Since Inception

+15.72%

(Cat Avg.)

Portfolio Summaryas of 30th April 2024

Equity928.8 Cr98.46%
Debt1.23 Cr0.13%
Others13.31 Cr1.41%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity119.1 Cr12.62%
Cipla LtdEquity63.36 Cr6.72%
Ajanta Pharma LtdEquity55.2 Cr5.85%
Dr Reddy's Laboratories LtdEquity49.63 Cr5.26%
Apollo Hospitals Enterprise LtdEquity41.63 Cr4.41%
Aurobindo Pharma LtdEquity34.6 Cr3.67%
Fortis Healthcare LtdEquity32.89 Cr3.49%
Krishna Institute of Medical Sciences LtdEquity32.53 Cr3.45%
Eris Lifesciences Ltd Registered ShsEquity31.01 Cr3.29%
Procter & Gamble Health LtdEquity30.77 Cr3.26%
Torrent Pharmaceuticals LtdEquity30.39 Cr3.22%
Gland Pharma LtdEquity29.68 Cr3.15%
Suven Pharmaceuticals LtdEquity29.06 Cr3.08%
Divi's Laboratories LtdEquity25.9 Cr2.75%
Zydus Lifesciences LtdEquity23.74 Cr2.52%
Glenmark Pharmaceuticals LtdEquity22.91 Cr2.43%
Metropolis Healthcare LtdEquity22.64 Cr2.40%
Alkem Laboratories LtdEquity20.55 Cr2.18%
Ipca Laboratories LtdEquity20.09 Cr2.13%
Jupiter Life Line Hospitals LtdEquity16.6 Cr1.76%
Pfizer LtdEquity16.18 Cr1.71%
Concord Biotech LtdEquity15.9 Cr1.69%
Syngene International LtdEquity14.69 Cr1.56%
Marksans Pharma LtdEquity13.78 Cr1.46%
Caplin Point Laboratories LtdEquity13.56 Cr1.44%
Max Healthcare Institute Ltd Ordinary SharesEquity13.24 Cr1.40%
Net Current AssetsCash13.19 Cr1.40%
Ami Organics LtdEquity12.71 Cr1.35%
Alembic Pharmaceuticals LtdEquity11.89 Cr1.26%
Windlas Biotech LtdEquity11.16 Cr1.18%
Abbott India LtdEquity10.58 Cr1.12%
Poly Medicure LtdEquity10.24 Cr1.09%
Orchid Pharma LtdEquity9.87 Cr1.05%
Rainbow Childrens Medicare LtdEquity9.43 Cr1.00%
Aster DM Healthcare Ltd Ordinary SharesEquity8.7 Cr0.92%
Sequent Scientific LtdEquity7.67 Cr0.81%
Vijaya Diagnostic Centre LtdEquity6.15 Cr0.65%
Star Health and Allied Insurance Co LtdEquity5.72 Cr0.61%
Indoco Remedies LtdEquity5.05 Cr0.54%
India (Republic of)Bond - Short-term Government Bills1.23 Cr0.13%
Clearing Corporation Of India Ltd. Std - MarginCash - Repurchase Agreement0.12 Cr0.01%

Allocation By Market Cap (Equity)

Large Cap Stocks

34.98%

Mid Cap Stocks

26.97%

Small Cap Stocks

36.50%

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare910.38 Cr96.51%
Basic Materials12.71 Cr1.35%
Financial Services5.72 Cr0.61%

Risk & Performance Ratios

Standard Deviation

This fund

14.41%

Cat. avg.

14.57%

Lower the better

Sharpe Ratio

This fund

0.68

Cat. avg.

0.69

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.16

Higher the better

Fund Managers

KG

Kamal Gada

Since May 2022

Additional Scheme Detailsas of 30th April 2024

ISININF789F01TO9Expense Ratio1.35%Exit Load1.00%Fund Size₹943 CrAge01 Jan 2013Lumpsum Minimum₹5,000Fund StatusOpen Ended Investment CompanyBenchmarkS&P BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr54.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹694.50 Cr57.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹694.50 Cr55.3%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹36.50 Cr52.9%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹161.86 Cr48.4%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹161.86 Cr45.4%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2236.01 Cr52.1%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2236.01 Cr49.9%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹639.49 Cr53.9%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹16.41 Cr51.7%

About the AMC

Total AUM

₹2,73,084 Cr

Address

UTI Towers, Gn Block, Mumbai, 400 051

Other Funds by UTI Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
UTI Innovation Fund Direct Growth

Very High Risk

0.9%1.0%₹644.99 Cr-
UTI Fixed Income Interval Fund Annual Plan I Direct Growth

Low Risk

-0.0%₹20.40 Cr6.9%
UTI Fixed Term Income Fund - Series XXXV-I (1260 Days) Direct Growth

Low to Moderate Risk

-0.0%-6.8%
UTI Fixed Term Income Fund - Series XXXV-III (1176 Days) Direct Growth

Low to Moderate Risk

-0.0%-6.7%
UTI FIIF Ser 2 Qt Interval V Direct Growth

Low Risk

-1.0%₹4.80 Cr6.9%
UTI Fixed Income Interval Fund Quarterly I Direct Growth

Low Risk

-0.0%₹10.46 Cr7.1%
UTI Fixed Inc Intvl Series2 Qt Intvl VI Direct Growth

Moderate Risk

-1.0%₹11.46 Cr7.2%
UTI-Fixed Term Income Fund - Series XXX-VI (1107 days) Direct Growth

Low to Moderate Risk

-0.0%-10.0%
UTI-Fixed Term Income Fund - Series XXX - VII (1294 days) Direct Growth

Low to Moderate Risk

-0.0%--
UTI Fixed Term Income Fund - Series XXXV-II (1223 Days) Direct Growth

Moderate Risk

---6.8%
UTI Fixed Income Interval Fund Annual Plan III Direct Growth

Low to Moderate Risk

-0.0%₹13.38 Cr6.7%
UTI Fixed Term Income Fund - Series XXXVI-I (1574 days) Direct Growth

Moderate Risk

-0.0%-6.6%
UTI Floater Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹1485.19 Cr7.3%
UTI Nifty 500 Value 50 Index Fund Direct Growth

Very High Risk

0.5%0.0%₹278.46 Cr92.6%
UTI Banking & PSU Debt Fund Direct Growth

Moderate Risk

0.3%0.0%₹947.38 Cr6.5%
UTI Focused Equity Fund Direct Growth

Very High Risk

0.6%1.0%₹2579.48 Cr35.9%
UTI Silver ETF Fund of Fund Direct Growth

Very High Risk

0.1%1.0%₹25.18 Cr19.8%
UTI Nifty200 Momentum 30 Index Fund Direct Growth

Very High Risk

0.5%0.0%₹5496.24 Cr70.5%
UTI Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹6229.00 Cr6.8%
UTI Corporate Bond Fund Direct Growth

Moderate Risk

0.3%0.0%₹3548.66 Cr7.0%
UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth

Very High Risk

0.5%0.0%₹187.71 Cr36.4%
UTI Arbitrage Fund Direct Growth

Low Risk

0.4%0.0%₹4887.58 Cr8.3%
UTI Small Cap Fund Direct Growth

Very High Risk

0.5%1.0%₹3791.34 Cr38.7%
UTI Ultra Short Term Fund Direct Growth

Moderate Risk

0.4%0.0%₹2349.32 Cr7.5%
UTI Credit Risk Fund Direct Growth

Moderately High risk

0.9%1.0%₹392.01 Cr7.2%
UTI Dividend Yield Fund Direct Growth

Very High Risk

1.4%1.0%₹3702.67 Cr44.9%
UTI Banking and Financial Services Fund Direct Growth

Very High Risk

1.2%1.0%₹1079.86 Cr22.5%
UTI Dynamic Bond Fund Direct Growth

Moderate Risk

0.7%0.0%₹570.62 Cr7.3%
UTI Hybrid Equity Fund Direct Growth

Very High Risk

1.3%1.0%₹5487.53 Cr32.1%
UTI Long Term Equity Fund Direct Growth

Very High Risk

0.9%0.0%₹3614.56 Cr32.3%
UTI Flexi Cap Fund Direct Growth

Very High Risk

0.9%1.0%₹24295.37 Cr20.4%
UTI Bond Fund Direct Growth

Moderate Risk

1.3%0.0%₹297.39 Cr5.6%
UTI Liquid Fund Cash Plan Direct Growth

Moderate Risk

0.2%0.0%₹23329.86 Cr7.3%
UTI Gilt Fund Direct Growth

Moderate Risk

0.7%0.0%₹631.89 Cr7.0%
UTI India Consumer Fund Direct Growth

Very High Risk

1.6%1.0%₹609.99 Cr35.3%
UTI Infrastructure Fund Direct Growth

Very High Risk

1.9%1.0%₹2183.97 Cr57.8%
UTI MNC Fund Direct Growth

Very High Risk

1.2%1.0%₹2839.28 Cr33.9%
UTI Master Share Unit Scheme Direct Growth

Very High Risk

0.8%1.0%₹12482.57 Cr27.7%
UTI Regular Savings Fund Direct Growth

Moderately High risk

1.2%1.0%₹1579.66 Cr13.7%
UTI Money Market Fund Direct Growth

Moderate Risk

0.2%0.0%₹14041.42 Cr7.6%
UTI Mid Cap Fund Direct Growth

Very High Risk

0.8%1.0%₹10474.79 Cr42.3%
UTI Value Opportunities Fund Direct Growth

Very High Risk

1.1%1.0%₹8931.67 Cr39.8%
UTI Healthcare Fund Direct Growth

Very High Risk

1.4%1.0%₹943.34 Cr52.0%
UTI Nifty 50 Index Fund Direct Growth

Very High Risk

0.2%0.0%₹16695.00 Cr24.6%
UTI Transportation & Logistics Fund Direct Growth

Very High Risk

0.8%1.0%₹3279.66 Cr60.4%
UTI Short Term Income Fund Direct Growth

Moderate Risk

0.4%0.0%₹2680.40 Cr7.5%
UTI - Treasury Advantage Fund Direct Growth

Moderate Risk

0.4%0.0%₹2629.59 Cr7.2%
UTI Multi Asset Fund Direct Growth

High Risk

1.1%1.0%₹1681.45 Cr39.4%
UTI Core Equity Fund Direct Growth

Very High Risk

1.2%1.0%₹2978.06 Cr47.5%
UTI Medium Term Fund Direct Growth

Moderate Risk

1.0%1.0%₹40.31 Cr6.6%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of UTI Healthcare Fund Direct Growth, as of 17-May-2024, is ₹250.97.
The fund has generated 52.01% over the last 1 year and 13.92% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 98.46% in equities, 0.13% in bonds, and 1.41% in cash and cash equivalents.
The fund managers responsible for UTI Healthcare Fund Direct Growth are:-
  1. Kamal Gada